(E)-3-[5-[[(3R)-1-[2-(2,6-difluorophenyl)ethyl]pyrrolidin-3-yl]amino]pyrazin-2-yl]-N-hydroxyprop-2-enamide

C19H21F2N5O2 — CID 135900404

IUPAC(E)-3-[5-[[(3R)-1-[2-(2,6-difluorophenyl)ethyl]pyrrolidin-3-yl]amino]pyrazin-2-yl]-N-hydroxyprop-2-enamide
SMILESO=C(/C=C/c1cnc(N[C@@H]2CCN(CCc3c(F)cccc3F)C2)cn1)NO
InChIInChI=1S/C19H21F2N5O2/c20-16-2-1-3-17(21)15(16)7-9-26-8-6-14(12-26)24-18-11-22-13(10-23-18)4-5-19(27)25-28/h1-5,10-11,14,28H,6-9,12H2,(H,23,24)(H,25,27)/b5-4+/t14-/m1/s1
InChIKeyLTKMRDYATQIKBY-ISZGNANSSA-N
MW389.41 g/mol
LogP2.00
Rot. Bonds7

About (E)-3-[5-[[(3R)-1-[2-(2,6-difluorophenyl)ethyl]pyrrolidin-3-yl]amino]pyrazin-2-yl]-N-hydroxyprop-2-enamide

(E)-3-[5-[[(3R)-1-[2-(2,6-difluorophenyl)ethyl]pyrrolidin-3-yl]amino]pyrazin-2-yl]-N-hydroxyprop-2-enamide (PubChem CID 135900404) has the molecular formula C19H21F2N5O2 and a molecular weight of 389.41 g/mol. Its IUPAC name is (E)-3-[5-[[(3R)-1-[2-(2,6-difluorophenyl)ethyl]pyrrolidin-3-yl]amino]pyrazin-2-yl]-N-hydroxyprop-2-enamide.

Molecular Properties

Compound Name(E)-3-[5-[[(3R)-1-[2-(2,6-difluorophenyl)ethyl]pyrrolidin-3-yl]amino]pyrazin-2-yl]-N-hydroxyprop-2-enamide
PubChem CID135900404
Molecular FormulaC19H21F2N5O2
Molecular Weight389.41 g/mol
Exact Mass389.17
IUPAC Name(E)-3-[5-[[(3R)-1-[2-(2,6-difluorophenyl)ethyl]pyrrolidin-3-yl]amino]pyrazin-2-yl]-N-hydroxyprop-2-enamide
SMILESO=C(/C=C/c1cnc(N[C@@H]2CCN(CCc3c(F)cccc3F)C2)cn1)NO
InChIInChI=1S/C19H21F2N5O2/c20-16-2-1-3-17(21)15(16)7-9-26-8-6-14(12-26)24-18-11-22-13(10-23-18)4-5-19(27)25-28/h1-5,10-11,14,28H,6-9,12H2,(H,23,24)(H,25,27)/b5-4+/t14-/m1/s1
InChIKeyLTKMRDYATQIKBY-ISZGNANSSA-N
XLogP2.00
TPSA90.38 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500389.41
LogP ≤ 52.00
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze (E)-3-[5-[[(3R)-1-[2-(2,6-difluorophenyl)ethyl]pyrrolidin-3-yl]amino]pyrazin-2-yl]-N-hydroxyprop-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (E)-3-[5-[[(3R)-1-[2-(2,6-difluorophenyl)ethyl]pyrrolidin-3-yl]amino]pyrazin-2-yl]-N-hydroxyprop-2-enamide?
The IUPAC name of (E)-3-[5-[[(3R)-1-[2-(2,6-difluorophenyl)ethyl]pyrrolidin-3-yl]amino]pyrazin-2-yl]-N-hydroxyprop-2-enamide (CID 135900404) is (E)-3-[5-[[(3R)-1-[2-(2,6-difluorophenyl)ethyl]pyrrolidin-3-yl]amino]pyrazin-2-yl]-N-hydroxyprop-2-enamide.
What is the SMILES notation for (E)-3-[5-[[(3R)-1-[2-(2,6-difluorophenyl)ethyl]pyrrolidin-3-yl]amino]pyrazin-2-yl]-N-hydroxyprop-2-enamide?
The canonical SMILES for (E)-3-[5-[[(3R)-1-[2-(2,6-difluorophenyl)ethyl]pyrrolidin-3-yl]amino]pyrazin-2-yl]-N-hydroxyprop-2-enamide is O=C(/C=C/c1cnc(N[C@@H]2CCN(CCc3c(F)cccc3F)C2)cn1)NO.
What is the InChIKey of (E)-3-[5-[[(3R)-1-[2-(2,6-difluorophenyl)ethyl]pyrrolidin-3-yl]amino]pyrazin-2-yl]-N-hydroxyprop-2-enamide?
The InChIKey is LTKMRDYATQIKBY-ISZGNANSSA-N. The full InChI is InChI=1S/C19H21F2N5O2/c20-16-2-1-3-17(21)15(16)7-9-26-8-6-14(12-26)24-18-11-22-13(10-23-18)4-5-19(27)25-28/h1-5,10-11,14,28H,6-9,12H2,(H,23,24)(H,25,27)/b5-4+/t14-/m1/s1.
What are the key properties of (E)-3-[5-[[(3R)-1-[2-(2,6-difluorophenyl)ethyl]pyrrolidin-3-yl]amino]pyrazin-2-yl]-N-hydroxyprop-2-enamide?
(E)-3-[5-[[(3R)-1-[2-(2,6-difluorophenyl)ethyl]pyrrolidin-3-yl]amino]pyrazin-2-yl]-N-hydroxyprop-2-enamide has a molecular weight of 389.41 g/mol, XLogP of 2.00, 7 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-3-[5-[[(3R)-1-[2-(2,6-difluorophenyl)ethyl]pyrrolidin-3-yl]amino]pyrazin-2-yl]-N-hydroxyprop-2-enamide is sourced from PubChem (CID 135900404), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).